Category - Pharmaceutical Industry

• Broad study tal­lies COVID-19’s toll in hos­pi­tals
• High­mark Health part­ners with Ver­ily sub­sidiary on chronic care is­sues
• ■ Pfizer plant boost­ing vac­cines has re­peat qual­ity of­fenses.
• The vac­cine revo­lu­tion is com­ing in­side tiny bub­bles of fat
• 68 new COVID-19 cases re­ported in Luzerne County
• Sato Phar­ma­ceu­ti­cal: Mar­ket­ing and monozukuri the dif­fer­en­tia­tors in drug devel­op­ment over­seas
• Peo­ple in Kuwait see ben­e­fits of TCM in pan­demic
• Have a case of a vari­ant? No one is go­ing to tell you
• Pan­demic raises con­cerns over im­pact of Medi­care pay re­struc­tur­ing on SNFs
• Vic­to­ria needs to ad­dress OST fees
• Drug com­pa­nies look for less toxic treat­ments for ag­ing HIV pa­tients
• SAVE MONEY ON MEDS
• HEALTH ’S AD­VI­SORY BOARD
• Re­defin­ing the care continuum
• Wake Up to the Pos­si­bil­i­ties of Reaching Your A1C Goal
• Brief Sum­mary of Im­por­tant Pa­tient In­for­ma­tion about DUPIXENT® (dupilumab) Rx Only
• Shyam S. Shekhawat, Manag­ing Di­rec­tor
• OU Health Physi­cians, Ok­la­homa Blues fail to reach new con­tract
• Democrats de­mo­nized Big Pharma. Now it’s sav­ing us from COVID-19.
• VIR­TUAL PA­TIENTS HONE DOC­TORS' PEO­PLE SKILLS
• More vet­er­ans can get shots
• ‘Peo­ple un­der­stand what a clin­i­cal trial is now’
• Af­ter Dems’ de­mo­niza­tion, Big Pharma now sav­ing us
• Swelling af­ter shots may lead to false alarms of cancer
• Drug dou­ble act can rid kid­neys of killer can­cer
• Com­pany agrees to $10.25 mil­lion set­tle­ment
• Al­tria asks FDA to help con­vince Amer­i­cans nico­tine isn’t that bad
• NFL, NFLPA seek al­ter­na­tives to opi­oids for pain man­age­ment
• LB Fi­nance do­nates ven­ti­la­tors to Apeksha Hos­pi­tal
• Vol­un­teers sought for 2nd vac­cine trial
• Mo­bi­liz­ing phar­ma­cists is key to our im­mu­niza­tion suc­cess
• Have you had your colonoscop­y yet?
• ‘TEACHER RE­CRUIT­MENT MUST BE TRANS­PAR­ENT’
• NTERNATION­AL clin­i­cal tri­als con­firm the hope that the cheap, widely avail­able drugs can help se­ri­ously ill pa­tients sur­vive. The World Health Or­ga­ni­za­tion is ex­pected to re­lease new guide­lines en­cour­ag­ing their use.
• WHO panel is­sues strong ad­vice against hy­drox­y­chloro­quine for COVID-19
• WHO: Waive patent rights
• Group seeks gov’t trans­parency in spend­ing P206-B health bud­get
• The new weapon in treat­ing IBS? A mood-booster!
• Preg­nant women should be fur­ther up in­oc­u­la­tion pri­or­ity list, say spe­cial­ists
• ITALY TESTS POW­ER­FUL AN­TI­BODY